Literature DB >> 10424347

The effect of conformation on the solution stability of linear vs. cyclic RGD peptides.

S J Bogdanowich-Knipp1, D S Jois, T J Siahaan.   

Abstract

The objective of this study was to evaluate the relationship between conformational flexibility and solution stability of a linear RGD peptide (Arg-Gly-Asp-Phe-OH; 1) and a cyclic RGD peptide (cyclo-(1, 6)-Ac-Cys-Arg-Gly-Asp-Phe-Pen-NH2; 2); as a function of pH. Previously, it was found that cyclic peptide 2 was 30-fold more stable than linear peptide 1. Therefore, this study was performed to explain the increase in chemical stability based on the preferred conformation of the peptides. Molecular dynamics simulations and energy minimizations were conducted to evaluate the backbone flexibility of both peptides under simulated pH conditions of 3, 7 and 10 in the presence of water. The reactive sites for degradation for both molecules were also followed during the simulations. The backbone of linear peptide 1 exhibited more flexibility than that of cyclic peptide 2, which was reflected in the rotation about the phi and psi dihedral angles. This was further supported by the low r.m.s. deviations of the backbone atoms for peptide 2 compared with those of peptide 1 that were observed among structures sampled during the molecular dynamics simulations. The presence of a salt bridge between the side chain groups of the Arg and Asp residues was also indicated for the cyclic peptide under simulated conditions of neutral pH. The increase in stability of the cyclic peptide 2 compared with the linear peptide 1, especially at neutral pH, is due to decreased structural flexibility imposed by the ring, as well as salt bridge formation between the side chains of the Arg and Asp residues in cyclic peptide 2. This rigidity would prevent the Asp side chain carboxylic acid from orienting itself in the appropriate position for attack on the peptide backbone.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10424347     DOI: 10.1034/j.1399-3011.1999.00055.x

Source DB:  PubMed          Journal:  J Pept Res        ISSN: 1397-002X


  13 in total

1.  Structural Basis of the Differential Binding of Engineered Knottins to Integrins αVβ3 and α5β1.

Authors:  Johannes F Van Agthoven; Hengameh Shams; Frank V Cochran; José L Alonso; James R Kintzing; Kiavash Garakani; Brian D Adair; Jian-Ping Xiong; Mohammad R K Mofrad; Jennifer R Cochran; M Amin Arnaout
Journal:  Structure       Date:  2019-07-25       Impact factor: 5.006

Review 2.  Dendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry.

Authors:  Su-Tang Lo; Amit Kumar; Jer-Tsong Hsieh; Xiankai Sun
Journal:  Mol Pharm       Date:  2013-01-24       Impact factor: 4.939

Review 3.  Peptide-based imaging agents for cancer detection.

Authors:  Xiaolian Sun; Yesen Li; Ting Liu; Zijing Li; Xianzhong Zhang; Xiaoyuan Chen
Journal:  Adv Drug Deliv Rev       Date:  2016-06-18       Impact factor: 15.470

4.  Comparison of Linear and Cyclic His-Ala-Val Peptides in Modulating the Blood-Brain Barrier Permeability: Impact on Delivery of Molecules to the Brain.

Authors:  Ahmed Alaofi; Ngoc On; Paul Kiptoo; Todd D Williams; Donald W Miller; Teruna J Siahaan
Journal:  J Pharm Sci       Date:  2016-02       Impact factor: 3.534

5.  Decarboxylative Peptide Macrocyclization through Photoredox Catalysis.

Authors:  Stefan J McCarver; Jennifer X Qiao; Joseph Carpenter; Robert M Borzilleri; Michael A Poss; Martin D Eastgate; Michael M Miller; David W C MacMillan
Journal:  Angew Chem Int Ed Engl       Date:  2016-11-17       Impact factor: 15.336

6.  Modular design, expression and characterization of novel bifunctional mutants of fibrolase with combined platelet aggregation-inhibition and fibrinolytic activity.

Authors:  Hui-Min Fang; Li Zhao; Ping Lu; San-Jun Chen; Zhen-Xia Bao; Yun-Fei Qin; Zhao-Yu Zhu; Jin-Mei Zhao; Jia Mai; Shou-Tao Zhang
Journal:  Protein J       Date:  2011-04       Impact factor: 2.371

7.  The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120.

Authors:  Nicos Karasavvas; Erik Billings; Mangala Rao; Constance Williams; Susan Zolla-Pazner; Robert T Bailer; Richard A Koup; Sirinan Madnote; Duangnapa Arworn; Xiaoying Shen; Georgia D Tomaras; Jeffrey R Currier; Mike Jiang; Craig Magaret; Charla Andrews; Raphael Gottardo; Peter Gilbert; Timothy J Cardozo; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Punnee Pitisuttithum; Jaranit Kaewkungwal; Robert Paris; Kelli Greene; Hongmei Gao; Sanjay Gurunathan; Jim Tartaglia; Faruk Sinangil; Bette T Korber; David C Montefiori; John R Mascola; Merlin L Robb; Barton F Haynes; Viseth Ngauy; Nelson L Michael; Jerome H Kim; Mark S de Souza
Journal:  AIDS Res Hum Retroviruses       Date:  2012-10-04       Impact factor: 2.205

Review 8.  The role of thiols and disulfides on protein stability.

Authors:  Maulik V Trivedi; Jennifer S Laurence; Teruna J Siahaan
Journal:  Curr Protein Pept Sci       Date:  2009-12       Impact factor: 3.272

9.  Detection of high-risk atherosclerotic plaques with ultrasound molecular imaging of glycoprotein IIb/IIIa receptor on activated platelets.

Authors:  Shengcun Guo; Shuxin Shen; Junfen Wang; He Wang; Meiyu Li; Ying Liu; Fanfan Hou; Yulin Liao; Jianping Bin
Journal:  Theranostics       Date:  2015-02-05       Impact factor: 11.556

10.  Just add water: hydratable, morphologically diverse nanocarrier powders for targeted delivery.

Authors:  Sharan Bobbala; Michael P Vincent; Evan A Scott
Journal:  Nanoscale       Date:  2021-07-08       Impact factor: 8.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.